Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Mostafa, A.
- The Beneficial Interaction Between Enalapril and Danazol in Normal Rat
Abstract Views :157 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmacology, College of Pharmacy, King Saud University, P.O Box 2457, Riyadh 11451, SA
1 Department of Pharmacology, College of Pharmacy, King Saud University, P.O Box 2457, Riyadh 11451, SA
Source
Scientia Pharmaceutica, Vol 70, No 2 (2002), Pagination: 165-175Abstract
Danazol, a weekly androgenic, heterocyclic compound with anabolic properties, is used primarily in the treatment of endometriosis and other gynecological complaints. Effects of co-administration of enalapril, an angiotensin converting enzyme inhibitor (ACE inhibitor) with danazol on some biochemical parameters in rats were studied. Treatment of rats with danazol (200mg/kg i.p) for 15 days induced a significant elevation of serum aspartate transaminase activity (AST, EC: 2.6.1.1), triglycerides (TG) and induced a significant decrease in serum cholesterol. However, enalapril treatment (20mg/kg i.p) for 15 days caused a significant elevation of serum alanine transaminase activity (ALT, EC: 2.6.1.2). Co-administration of danazol and enalapril significantly lowered the elevated levels of serum transaminases enzyme activities and serum TG. It could be concluded that long term treatment with enalapril might be beneficial in patients danazol in clinical situations through protection against undesirable side effects.
References
- Packard C.J., Shepher D.J. (1994), Acta. Obstet. Gyrrecol. Scand. Suppl. 159: 35.
- Jenkin G. (Review) (1980), NZ. J. Obstet. Gynaecol. 20: 113.
- Tamora K., Okamoto R., Takeo S., Kogo H. (1991), Eur. J. Pharmacol. 24:317.
- Kogo H., Takasaki K., Yatabe Y., Nishikawa M., takeo S., Tamura K. (1992), Eur. J. Pharmacol 28:69.
- Soma M. R., Meschia M., Bruschi F., Morrisett J. D., Paoletti R., Fumagalli, Crosignani P. (1994), Chem. Phys. Lipids 67-68: 345.
- Sangha G.K., Chopra N. (1998), Indian J. Physiol. Pharmacol. 42(2): 252.
- Dixit V.P., Agrawal M., Varma M. (1981), Endokrinologie 77(1): 30.
- Barbieri R.R., Ryan K.J. (1981), Am. J. Obstet. Gynecol. 141 :453.
- Ondetti M. A., Rubin B., Cushman D. W. (1977), Science 196:441.
- Reitman S., Frankel S. (1956), Am. J. Clin. Pathol. 28:56
- Fujjta H. (1939), J. Biochem (Japan) 30:69
- Swanson J., Wilkinson J. (1972) In:Cooper GR(ed) Standard methods.
- Trinder P. (1969), Ann. Clin. Biochem. 6: 24.
- Hallet C.J., Cooke J. G. (1977), Clin. Chem. Acta 35:33.
- Bonsness R.W., Taussky H.N. (1945), J. Biol. Chem. 158:581.
- Luciano A.A., Wallace R.B., Sherman B.M.(1982), Atherosclerosis 43: 133.
- Fahraeus L., Larsson-Cohn U., Ljungberg S., Waiientin L. (1984), Fertil Steril 42: 52.
- Henzl M.R., Carson S.L., Moghissi K., Buttram V.C., Berquist C., Jacobson. J.N. (1989), N.Engl. J. Med. 318: 485.
- Tlimaa S., Rannberg L., Pentilla I., Kauppila, Puolakka J. (1989) Fertil Steril 52: 31.
- Crook D., Gardner R., Nolan J., Stevenson J. C., Shaw R. W. (1989), Hormone Res. 32: 157.
- Booker M. W., Turner P. R., Lewis B., Whitehead M. I. (1987), J. Obstet. Gynaecol. 8:88.
- Valimaki M., Nilsson C. G., Roine R., Ylikorkal A. O. (1989), J. Clin. Endocrinol. Metab. 69: 1097.
- Breckenridge A. (1988), Br. Med. J. 296: 618.